These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 167651)

  • 21. Pituitary gonadotropin-releasing hormone receptors. Effects of castration, steroid replacement, and the role of gonadotropin-releasing hormone in modulating receptors in the rat.
    Frager MS; Pieper DR; Tonetta SA; Duncan JA; Marshall JC
    J Clin Invest; 1981 Mar; 67(3):615-23. PubMed ID: 6259205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic and clinical studies with luteinizing hormone-releasing hormone (LH-RH) and its analogues.
    Schally AV; Kastin AJ; Arimura A; Coy D; Coy E; Debeljuk L; Redding TW
    J Reprod Fertil Suppl; 1973 Dec; 20(0):119-36. PubMed ID: 4600939
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of pituitary response to gonadotropin releasing hormone by urinary gonadotropin inhibiting substance.
    Damian E; Ianăş O; Bădescu I; Oprescu M
    Endocrinologie; 1981; 19(1):29-32. PubMed ID: 6794139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin-releasing hormone.
    Valenta LJ; Zolman JC
    N Engl J Med; 1977 Sep; 297(13):725. PubMed ID: 197408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Luteostimulin releasing hormone (LH-RH) in the investigation of hypophysogonadal abnormalities in children and adolescents].
    Job JC; Garnier PE; Chaussain JL; Binet E; Canlorbe P; Rivaille P; Milhaud G
    Nouv Presse Med; 1972 Jun; 1(24):1633-6. PubMed ID: 4402798
    [No Abstract]   [Full Text] [Related]  

  • 26. Estrogen modulation of pituitary LHRH receptor in the rat: in vivo and in vitro studies.
    Heber D; Odell WD
    Am J Physiol; 1979 Aug; 237(2):E136-41. PubMed ID: 223452
    [No Abstract]   [Full Text] [Related]  

  • 27. LH-RH interaction with the pituitary plasma membrane is affected by sex steroids.
    Spona J
    FEBS Lett; 1974 Feb; 39(2):221-4. PubMed ID: 4368885
    [No Abstract]   [Full Text] [Related]  

  • 28. Distribution of radioactivity after administration of 125I-labelled luteinizing releasing hormone in rats.
    Isidori A; Spera G; Costa T; D'Alessio A; Fraioli F
    Experientia; 1974 Oct; 30(10):1211-3. PubMed ID: 4611785
    [No Abstract]   [Full Text] [Related]  

  • 29. The restoration of the function of the hypophyseal-gonadal system following its prolonged suppression by luliberin agonists.
    Goncharova ND; Mkhitarova LA; Gogiladze EM
    Neurosci Behav Physiol; 1993; 23(1):1-5. PubMed ID: 8464539
    [No Abstract]   [Full Text] [Related]  

  • 30. On the function of arginine in luteinizing hormone-releasing hormone.
    Hazum E; Fridkin M; Meidan R; Koch Y
    FEBS Lett; 1977 Apr; 76(2):187-90. PubMed ID: 324800
    [No Abstract]   [Full Text] [Related]  

  • 31. Gonadotropin-releasing hormone: physiological and endocrinological aspects.
    Klingmüller D; Schweikert HU
    Recent Results Cancer Res; 1992; 124():1-6. PubMed ID: 1615214
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood and urine clearance of luteinizing hormone releasing hormone in man measured by radioimmunoassay.
    Jeffcoate SL; Greenwood RH; Holland DT
    J Endocrinol; 1974 Feb; 60(2):305-14. PubMed ID: 4593135
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: Possible control of luteinising-hormone-releasing hormone by enzymatic degradation.
    Griffiths EC; Hooper KC; Jeffcoate SL; Holland DT
    Lancet; 1973 Oct; 2(7833):862. PubMed ID: 4126674
    [No Abstract]   [Full Text] [Related]  

  • 34. Do some traditional hypophysiotropic hormones play nontraditional roles in the neurohypophysis? Implications of immunocytochemical studies.
    Anthony EL; Bruhn TO
    Ann N Y Acad Sci; 1993 Jul; 689():469-72. PubMed ID: 8373029
    [No Abstract]   [Full Text] [Related]  

  • 35. Gonadal activity and chemotherapy-induced gonadal damage.
    JAMA; 1988 Oct; 260(14):2064-6. PubMed ID: 3047451
    [No Abstract]   [Full Text] [Related]  

  • 36. [Symposium of "releasing factors"].
    Bergsjo P
    Tidsskr Nor Laegeforen; 1973 Sep; 93(27):2052-5. PubMed ID: 4148828
    [No Abstract]   [Full Text] [Related]  

  • 37. Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways.
    Liu J; Maccalman CD; Wang YL; Leung PC
    Mol Endocrinol; 2009 Jul; 23(7):1014-21. PubMed ID: 19372239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin-releasing hormone.
    Yen SS
    Annu Rev Med; 1975; 26():403-17. PubMed ID: 167651
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical effects and uses of hypothalamic releasing and inhibiting factors.
    Gual C
    Front Neuroendocrinol; 1973; 0(0):89-131. PubMed ID: 4212997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.